Walleye Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Walleye Trading’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,400	Closed	-$220K	–	5208
2020 Q3	$220K	Buy	23,400 +20,200	+631%	+$192K	﹤0.01%	2924
2020 Q2	$24K	Buy	+3,200	New	+$24.5K	﹤0.01%	3958
2019 Q3	–	Sell	-18,000	Closed	-$180K	–	4619
2019 Q2	$180K	Buy	+18,000	New	+$194K	﹤0.01%	3019
2019 Q1	–	Sell	-9,900	Closed	-$150K	–	5020
2018 Q4	$150K	Buy	+9,900	New	+$189K	﹤0.01%	3641
2017 Q4	–	Sell	-1,500	Closed	-$27	–	4771
2017 Q3	$27	Sell	1,500 -1,400	-48%	-$26.1K	﹤0.01%	3886
2017 Q2	$55	Buy	+2,900	New	+$57.5K	﹤0.01%	3853

Walleye Trading's AMAG Position: Q2 2020 in Review

Walleye Trading sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 9,627 shares — an estimated $73.7K sold.

Walleye Trading first reported a position in AMAG in Q2 2015 and held it in 8 quarters. The position peaked at $390K in Q4 2016. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

Walleye Trading reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 9,627 AMAG Pharmaceuticals shares in Q2 2020, an estimated $73.7K.
Walleye Trading first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 8 quarters.
Walleye Trading's AMAG Pharmaceuticals position peaked at $390K in Q4 2016.
119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.